Product Information
OXYBUTYNIN CL ER 15 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.1169 per EA under NDC 16729031901. Its NADAC has been published 497 times since Dec 28, 2016.
FDA first approved this application on Feb 29, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729031901
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
6/17/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207138FDA Approved
2/29/2016
TE Code
AB
On Market Since
12/14/2016
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN CL ER 15 MG TABLET has been published 497 times since Dec 28, 2016, and over the history we have for it it has declined 86.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1169 per EA |
|---|---|
| All-time high | $0.8594 (Jan 11, 2017) |
| All-time low | $0.0936 (Apr 17, 2024) |
| 52-week high | $0.1336 |
| 52-week low | $0.1161 |
| Median price | $0.2477 |
| Average price | $0.2914 |
| Largest weekly change | +38.9% (May 22, 2024) |
| Weeks tracked | 497 |
| Tracking since | Dec 28, 2016 |
1W
N/A
1M
N/A
3M
+0.6%
6M
-0.8%
1Y
-12.5%
3Y
-10.9%
5Y
-55.2%
All
-86.4%
Last surveyed Jul 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the oxybutynin chloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXYBUTYNIN CL ER 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN CL ER 15 MG TABLET, manufactured by Accord Healthcare Inc., is $0.1169 per EA (NDC 16729031901), effective Jul 1, 2026.
How has the price of OXYBUTYNIN CL ER 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN CL ER 15 MG TABLET has declined 86.4%. It has been tracked across 497 weekly CMS publications since Dec 28, 2016.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN CL ER 15 MG TABLET?
Since Dec 28, 2016, the NADAC for OXYBUTYNIN CL ER 15 MG TABLET has ranged from a low of $0.0936 (Apr 17, 2024) to a high of $0.8594 (Jan 11, 2017), with a median of $0.2477 per EA.
Are there cheaper alternatives to OXYBUTYNIN CL ER 15 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of OXYBUTYNIN CL ER 15 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OXYBUTYNIN CL ER 15 MG TABLET?
OXYBUTYNIN CL ER 15 MG TABLET (NDC 16729031901) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.